95 related articles for article (PubMed ID: 20930660)
1. Postoperative serum C-reactive protein levels in non-small cell lung cancer patients.
Hara M; Yonei A; Ayabe T; Tomita M; Nakamura K; Onitsuka T
Ann Thorac Cardiovasc Surg; 2010 Apr; 16(2):85-90. PubMed ID: 20930660
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum C-reactive protein level in non-small cell lung cancer.
Hara M; Matsuzaki Y; Shimuzu T; Tomita M; Ayabe T; Enomoto Y; Onitsuka T
Anticancer Res; 2007; 27(4C):3001-4. PubMed ID: 17695486
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of C-reactive protein in patients with stage I non-small cell lung cancer].
Shen L; Li ZM; Lu S
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):442-6. PubMed ID: 21875485
[TBL] [Abstract][Full Text] [Related]
4. Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer.
Lee JG; Cho BC; Bae MK; Lee CY; Park IK; Kim DJ; Ahn SV; Chung KY
Lung Cancer; 2009 Jan; 63(1):106-10. PubMed ID: 18513823
[TBL] [Abstract][Full Text] [Related]
5. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma.
Hashimoto K; Ikeda Y; Korenaga D; Tanoue K; Hamatake M; Kawasaki K; Yamaoka T; Iwatani Y; Akazawa K; Takenaka K
Cancer; 2005 May; 103(9):1856-64. PubMed ID: 15779015
[TBL] [Abstract][Full Text] [Related]
6. Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer.
Tomita M; Shimizu T; Ayabe T; Nakamura K; Onitsuka T
Anticancer Res; 2012 Aug; 32(8):3535-8. PubMed ID: 22843942
[TBL] [Abstract][Full Text] [Related]
7. Preresection serum C-reactive protein measurement and survival among patients with resectable non-small cell lung cancer.
Alifano M; Falcoz PE; Seegers V; Roche N; Schussler O; Younes M; Antonacci F; Forgez P; Dechartres A; Massard G; Damotte D; Régnard JF
J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1161-7. PubMed ID: 21872279
[TBL] [Abstract][Full Text] [Related]
8. Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer.
Jones JM; McGonigle NC; McAnespie M; Cran GW; Graham AN
Lung Cancer; 2006 Jul; 53(1):97-101. PubMed ID: 16698114
[TBL] [Abstract][Full Text] [Related]
9. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
Hotta K; Segawa Y; Takigawa N; Kishino D; Saeki H; Nakata M; Mandai K; Eguchi K
Anticancer Res; 2000; 20(3B):2177-80. PubMed ID: 10928173
[TBL] [Abstract][Full Text] [Related]
11. The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies.
Petrella F; Radice D; Borri A; Galetta D; Gasparri R; Solli P; Veronesi G; Spaggiari L
Eur J Cardiothorac Surg; 2011 May; 39(5):738-44. PubMed ID: 20952203
[TBL] [Abstract][Full Text] [Related]
12. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis.
Sawabata N; Maeda H; Yokota S; Takeda S; Koma M; Tokunaga T; Ito M
Cancer; 2004 Aug; 101(4):803-9. PubMed ID: 15305413
[TBL] [Abstract][Full Text] [Related]
13. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.
Wang CY; Huang MS; Huang MH; Lee HC; Hsu HS
J Surg Res; 2010 Oct; 163(2):e45-50. PubMed ID: 20638687
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung.
Fukai R; Sakao Y; Sakuraba M; Oh S; Shiomi K; Sonobe S; Saitoh Y; Miyamoto H
Eur J Cardiothorac Surg; 2007 Sep; 32(3):440-4. PubMed ID: 17643308
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
16. Impact of preoperative hemoglobin level on survival of non-small cell lung cancer patients.
Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
Anticancer Res; 2008; 28(3B):1947-50. PubMed ID: 18630486
[TBL] [Abstract][Full Text] [Related]
17. Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancer.
Suzuki H; Ishikawa S; Satoh H; Ishikawa H; Sakai M; Yamamoto T; Onizuka M; Sakakibara Y
Eur J Cardiothorac Surg; 2007 Oct; 32(4):648-52. PubMed ID: 17707649
[TBL] [Abstract][Full Text] [Related]
18. [The quantitative evaluation of the serum acute phase proteins (APP) of patients undergoing a curative resection for non-small cell lung cancer (NSCLC)].
Kasprzyk M; Dyszkiewicz W; Zwaruń D; Szydlik S; Leśniewska K; Krzyzanowski M
Przegl Lek; 2006; 63(10):936-40. PubMed ID: 17288188
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the prognosis of patients with stage I non-small cell lung cancer with respect to predicted postoperative lung function].
Koizumi K; Tanaka S; Haraguchi S; Matsushima S; Gomibuchi M
Nihon Kyobu Geka Gakkai Zasshi; 1996 Feb; 44(2):162-8. PubMed ID: 8717264
[TBL] [Abstract][Full Text] [Related]
20. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]